Jim Simons's position in Editas Medicine is currently worth $6.72M. That's 0.01% of their equity portfolio (1215th largest holding). The investor owns 1.64% of the outstanding Editas Medicine stock. The first Editas Medicine trade was made in Q2 2016. Since then Jim Simons bought shares fifteen more times and sold shares on fifteen occasions. The stake costed the investor $6.4M, netting the investor a gain of 5.0% so far.